Innate Pharma SA (IPHA)
2.46
+0.06
(+2.50%)
USD |
NASDAQ |
Apr 26, 16:00
Innate Pharma Price to Book Value: 3.466 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 3.466 |
| April 25, 2024 | 3.382 |
| April 24, 2024 | 3.466 |
| April 23, 2024 | 3.340 |
| April 22, 2024 | 3.417 |
| April 19, 2024 | 3.438 |
| April 18, 2024 | 3.311 |
| April 17, 2024 | 3.396 |
| April 16, 2024 | 3.650 |
| April 15, 2024 | 3.41 |
| April 12, 2024 | 3.495 |
| April 11, 2024 | 3.495 |
| April 10, 2024 | 3.551 |
| April 09, 2024 | 3.664 |
| April 08, 2024 | 3.664 |
| April 05, 2024 | 3.568 |
| April 04, 2024 | 3.523 |
| April 03, 2024 | 3.621 |
| April 02, 2024 | 3.551 |
| April 01, 2024 | 3.776 |
| March 28, 2024 | 4.058 |
| March 27, 2024 | 3.354 |
| March 26, 2024 | 3.438 |
| March 25, 2024 | 3.382 |
| March 22, 2024 | 3.343 |
| Date | Value |
|---|---|
| March 21, 2024 | 3.396 |
| March 20, 2024 | 3.523 |
| March 19, 2024 | 3.424 |
| March 18, 2024 | 3.368 |
| March 15, 2024 | 3.558 |
| March 14, 2024 | 3.551 |
| March 13, 2024 | 3.523 |
| March 12, 2024 | 3.664 |
| March 11, 2024 | 3.445 |
| March 08, 2024 | 3.805 |
| March 07, 2024 | 3.678 |
| March 06, 2024 | 3.685 |
| March 05, 2024 | 3.621 |
| March 04, 2024 | 3.706 |
| March 01, 2024 | 3.692 |
| February 29, 2024 | 3.692 |
| February 28, 2024 | 3.72 |
| February 27, 2024 | 3.786 |
| February 26, 2024 | 3.579 |
| February 23, 2024 | 3.748 |
| February 22, 2024 | 3.664 |
| February 21, 2024 | 3.565 |
| February 20, 2024 | 3.650 |
| February 16, 2024 | 3.579 |
| February 15, 2024 | 3.664 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.230
Minimum
Mar 17 2020
5.287
Maximum
Jan 17 2023
2.530
Average
2.223
Median
Feb 25 2022
Price to Book Value Benchmarks
| Sanofi SA | 1.499 |
| DBV Technologies SA | 0.9357 |
| Cellectis SA | 2.356 |
| PHAXIAM Therapeutics SA (DELISTED) | 0.4731 |
| Genfit SA | 2.317 |
Price to Book Value Related Metrics
| PS Ratio | 3.511 |
| Price | 2.46 |
| Earnings Yield | -3.93% |
| Market Cap | 198.87M |